M. BENKABBOUR

Effects of SGLT2 Inhibitors on Left Ventricular Ejection Fraction (LVEF) in Coronary Patients: A Prospective Single-center Study

F. ARABI, M. BENKABBOUR, F. HAFFANE, A. AITYAHYA & M. El Hattaoui · Cardiology and Angiology: An International Journal · 2025

Objective: To evaluate the effect of sodium-glucose co-transporter 2 inhibitors (SGLT2i) on left ventricular ejection fraction (LVEF) in coronary patients, whether revascularized or not. Methods: A prospective single-center study was conducted in 100 patients with ischemic cardio...

Open access Research Article 10.9734/ca/2025/v14i3494

Pheochromocytoma-induced Myocarditis: A Case Report and Literature Review

F. ARABI, M. BENKABBOUR, J. Elmasrioui, S. Elkarimi & M. El Hattaoui · Cardiology and Angiology: An International Journal · 2025

Background: Pheochromocytoma is a rare catecholamine-secreting tumor that may present with various cardiovascular manifestations, including acute myocarditis. The excessive release of catecholamines can cause direct myocardial injury through mechanisms such as vasospasm, oxidativ...

Open access Research Article 10.9734/ca/2025/v14i3493